Skip to Main Content

Author Details

Natalie J??ger
Hopp Children's Cancer Center Heidelberg (KiTZ)
2010
64
28
Antoine Forget (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37875569Author Correction: Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology.Nat Med2024
37875569Author Correction: Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology.Nat Med2024
36928815Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology.Nat Med2023
37679810Transcriptional immunogenomic analysis reveals distinct immunological clusters in paediatric nervous system tumours.Genome Med2023
37277823Group-specific cellular metabolism in Medulloblastoma.J Transl Med2023
370855393D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymoma.Nat Commun2023
37020198The potential of PARP as a therapeutic target across pediatric solid malignancies.BMC Cancer2023
36576005Revana: a comprehensive tool for regulatory variant analysis and visualization of cancer genomes.Bioinformatics2023
36702933Comprehensive analysis of mutational signatures reveals distinct patterns and molecular processes across 27 pediatric cancers.Nat Cancer2023
36495208Reply to Evans and Woodward.J Natl Cancer Inst2023
37004196Reply to Li and Colleagues.J Natl Cancer Inst2023
36928815Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology.Nat Med2023
37364231Outcome of Children and Adolescents With Relapsed/Refractory/Progressive Malignancies Treated With Molecularly Informed Targeted Drugs in the Pediatric Precision Oncology Registry INFORM.JCO Precis Oncol2023
37501103Mitochondrial DNA mutations in Medulloblastoma.Acta Neuropathol Commun2023
37501103Mitochondrial DNA mutations in Medulloblastoma.Acta Neuropathol Commun2023
37679810Transcriptional immunogenomic analysis reveals distinct immunological clusters in paediatric nervous system tumours.Genome Med2023
37020198The potential of PARP as a therapeutic target across pediatric solid malignancies.BMC Cancer2023
370855393D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymoma.Nat Commun2023
37277823Group-specific cellular metabolism in Medulloblastoma.J Transl Med2023
37004196Reply to Li and Colleagues.J Natl Cancer Inst2023
37364231Outcome of Children and Adolescents With Relapsed/Refractory/Progressive Malignancies Treated With Molecularly Informed Targeted Drugs in the Pediatric Precision Oncology Registry INFORM.JCO Precis Oncol2023
36576005Revana: a comprehensive tool for regulatory variant analysis and visualization of cancer genomes.Bioinformatics2023
36702933Comprehensive analysis of mutational signatures reveals distinct patterns and molecular processes across 27 pediatric cancers.Nat Cancer2023
36495208Reply to Evans and Woodward.J Natl Cancer Inst2023
33476720Bioinformatics workflows for clinical applications in precision oncology.Semin Cancer Biol2022
35445187The genomic landscape of pediatric renal cell carcinomas.iScience2022
35802025FOXR2 Is an Epigenetically Regulated Pan-Cancer Oncogene That Activates ETS Transcriptional Circuits.Cancer Res2022
35475274Predictive modeling of resistance to SMO inhibition in a patient-derived orthotopic xenograft model of SHH medulloblastoma.Neurooncol Adv2022
35980168Heterozygous BRCA1 and BRCA2 and Mismatch Repair Gene Pathogenic Variants in Children and Adolescents With Cancer.J Natl Cancer Inst2022
35715818MiR-1248: a new prognostic biomarker able to identify supratentorial hemispheric pediatric low-grade gliomas patients associated with progression.Biomark Res2022
36575299Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM.NPJ Precis Oncol2022
33476720Bioinformatics workflows for clinical applications in precision oncology.Semin Cancer Biol2022
34848323iTReX: Interactive exploration of mono- and combination therapy dose response profiling data.Pharmacol Res2022
34963094Target Actionability Review: a systematic evaluation of replication stress as a therapeutic target for paediatric solid malignancies.Eur J Cancer2022
35445187The genomic landscape of pediatric renal cell carcinomas.iScience2022
35802025FOXR2 Is an Epigenetically Regulated Pan-Cancer Oncogene That Activates ETS Transcriptional Circuits.Cancer Res2022
35475274Predictive modeling of resistance to SMO inhibition in a patient-derived orthotopic xenograft model of SHH medulloblastoma.Neurooncol Adv2022
35715818MiR-1248: a new prognostic biomarker able to identify supratentorial hemispheric pediatric low-grade gliomas patients associated with progression.Biomark Res2022
36575299Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM.NPJ Precis Oncol2022
35980168Heterozygous BRCA1 and BRCA2 and Mismatch Repair Gene Pathogenic Variants in Children and Adolescents With Cancer.J Natl Cancer Inst2022
34963094Target Actionability Review: a systematic evaluation of replication stress as a therapeutic target for paediatric solid malignancies.Eur J Cancer2022
34848323iTReX: Interactive exploration of mono- and combination therapy dose response profiling data.Pharmacol Res2022
32822486Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified medulloblastoma.Neuro Oncol2021
33545065H3.3-K27M drives neural stem cell-specific gliomagenesis in a human iPSC-derived model.Cancer Cell2021
33585982Integrated molecular and clinical analysis of low-grade gliomas in children with neurofibromatosis type 1 (NF1).Acta Neuropathol2021
32822486Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified medulloblastoma.Neuro Oncol2021
33175161An extracellular vesicle-related gene expression signature identifies high-risk patients in medulloblastoma.Neuro Oncol2021
34615983A systematic analysis of genetic interactions and their underlying biology in childhood cancer.Commun Biol2021
34417833PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum.Acta Neuropathol2021
33545065H3.3-K27M drives neural stem cell-specific gliomagenesis in a human iPSC-derived model.Cancer Cell2021
  • 1 - 50 of 128

Recommended Authors

Zachary L Skidmore
Washington University in St. Louis School of Medicine
Career Start Year 2015
Number of shared co-authors 5
Komal S Rathi
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year 2014
Number of shared co-authors 11
Ninad Oak
St. Jude Children's Research Hospital
Career Start Year 2014
Number of shared co-authors 9
Jaime M Guidry Auvil
National Cancer Institute
Career Start Year 2013
Number of shared co-authors 25
Richard de Borja
The Hospital for Sick Children
Career Start Year 2012
Number of shared co-authors 31
Hiromichi Suzuki
Graduate School of Medicine, Kyoto University
Career Start Year 2012
Number of shared co-authors 55
Hiroko Tanaka
Tokyo Medical and Dental University
Career Start Year 2012
Number of shared co-authors 7
Krutika S Gaonkar
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year 2012
Number of shared co-authors 9
Jiguang Wang
The Hong Kong University of Science and Technology
Career Start Year 2012
Number of shared co-authors 3
Gunes Gundem
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 16
Ignaty Leshchiner
Broad Institute of Massachusetts Institute of Technology and Harvard
Career Start Year 2008
Number of shared co-authors 6
Siyuan Zheng
Greehey Children's Cancer Research Institute
Career Start Year 2007
Number of shared co-authors 30
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 2
Chip Stewart
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 37
Roel G W Verhaak
Yale School of Medicine
Career Start Year 2004
Number of shared co-authors 39
Peter Van Loo
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 28
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 9
Michael D McLellan
McDonnell Genome Institute, Washington University in St. Louis
Career Start Year 2003
Number of shared co-authors 16
Malachi Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 13
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 18
Olivier Elemento
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 15
Vladimir Makarov
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 1
Michael N Edmonson
St. Jude Children's Research Hospital
Career Start Year 1999
Number of shared co-authors 23
Xiang Chen
St. Jude Children's Research Hospital
Career Start Year 1999
Number of shared co-authors 27
Carrie Sougnez
The Broad Institute of Harvard and MIT
Career Start Year 1998
Number of shared co-authors 31
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 51
Donald W Parsons
Texas Children's Hospital
Career Start Year 1996
Number of shared co-authors 44
Robert S Fulton
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1994
Number of shared co-authors 41
John Easton
St Jude Children's Research Hospital
Career Start Year 1991
Number of shared co-authors 42
Elaine R Mardis
The Ohio State University
Career Start Year 1988
Number of shared co-authors 52

Collaborators

Stefan M Pfister
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 49
David T W Jones
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 33
Marcel Kool
Hopp Children's Cancer Center (KiTZ)
Co-authored papers 26
Olaf Witt
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 20
Andrey Korshunov
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 18
Till Milde
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 17
Peter Lichter
German Cancer Research Center (DKFZ)
Co-authored papers 16
Paul A Northcott
St Jude Children's Research Hospital
Co-authored papers 14
Roland Eils
Berlin Institute of Health (BIH) and Charite
Co-authored papers 14
Andreas von Deimling
Co-authored papers 13
Michael D Taylor
The Hospital for Sick Children
Co-authored papers 12
Benedikt Brors
German Cancer Research Center (DKFZ)
Co-authored papers 11
Stefan Rutkowski
University Medical Center Hamburg-Eppendorf
Co-authored papers 11
Marina Ryzhova
N.N. Burdenko Neurosurgical Institute
Co-authored papers 11
Jan O Korbel
European Bioinformatics Institute (EMBL-EBI)
Co-authored papers 11
Martin Sill
Co-authored papers 10
Jan Koster
Amsterdam University Medical Centers location AMC
Co-authored papers 10
Marc Zapatka
Co-authored papers 10
Felix Sahm
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 9
Nada Jabado
McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH)
Co-authored papers 9
Dominik Sturm
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 9
Stephan Wolf
Co-authored papers 8
Barbara Hutter
National Center for Tumor Diseases (NCT) Heidelberg
Co-authored papers 8
Matthias Schlesner
University of Augsburg
Co-authored papers 7
Hendrik Witt
Co-authored papers 7
David Malkin
Hospital for Sick Children
Co-authored papers 7
Elke Pfaff
Co-authored papers 7
Marc Remke
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers 7
Marie-Laure Yaspo
Max Planck Institute for Molecular Genetics
Co-authored papers 7
Ulrich Sch??ller
University Medical Center Hamburg-Eppendorf
Co-authored papers 7
Release 1.2